Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHWAR vs Ifosfamide/Cisplatin in Uterine Carcinosarcoma
NCT00002546Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Dec 1993
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cisplatin, ifosfamide in uterine carcinosarcoma (UCS), sponsored by GOG Foundation. Started Dec 1993; status: completed.
02
Drugs
cisplatinifosfamide
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT00002546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002546.